Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Takahisa Gono & Masataka Kuwana. (2023) New paradigm in the treatment of myositis-associated interstitial lung disease. Expert Review of Respiratory Medicine 17:5, pages 397-411.
Read now
Read now
Masanori Hanaoka, Yasuhiro Katsumata, Hidenaga Kawasumi, Yasushi Kawaguchi & Hisashi Yamanaka. (2019) KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker. Modern Rheumatology 29:4, pages 625-632.
Read now
Read now
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2019) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Modern Rheumatology 29:1, pages 1-19.
Read now
Read now
Youhei Fujiki, Takuya Kotani, Kentaro Isoda, Takaaki Ishida, Takeshi Shoda, Shuzo Yoshida, Tohru Takeuchi & Shigeki Makino. (2018) Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients. Modern Rheumatology 28:1, pages 133-140.
Read now
Read now
Kazuhiro Kurasawa & Satoko Arai. (2014) Optimal management of interstitial lung disease associated with dermatomyositis/polymyositis: lessons from the Japanese experience. Orphan Drugs: Research and Reviews 4, pages 93-107.
Read now
Read now
Yuting Zhu, Jianhua Fu, Kai You, Linlin Jin, Min Wang, Danchi Lu & Xindong Xue. (2013) Changes in pulmonary tissue structure and KL-6/MUC1 expression in a newborn rat model of hyperoxia-Induced bronchopulmonary dysplasia. Experimental Lung Research 39:10, pages 417-426.
Read now
Read now
Articles from other publishers (29)
Janelle Vu Pugashetti, Dinesh Khanna, Ella A. Kazerooni & Justin Oldham. (2023) Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease. Immunology and Allergy Clinics of North America 43:2, pages 411-433.
Crossref
Crossref
Xiaomeng Li, Yongmei Liu, Linlin Cheng, Yuan Huang, Songxin Yan, Haolong Li, Haoting Zhan & Yongzhe Li. (2022)
Roles of biomarkers in
anti‐MDA5
‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
. Journal of Clinical Laboratory Analysis 36:11.
Crossref
Crossref
Masaru Ejima, Tsukasa Okamoto, Takafumi Suzuki & Yasunari Miyazaki. (2022) Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis. Respiratory Investigation 60:3, pages 369-378.
Crossref
Crossref
Tatsuya Kawasaki, Mitsuru Imamura, Hiroko Nagafuchi, Shotaro Suzuki, Mariko Mouri, Yoshiki Ishizaki, Keiichi Sakurai, Machiko Mizushima, Kumiko Tonooka, Yukiko Takakuwa, Seido Ooka, Takahiko Sugihara & Kimito Kawahata. (2022) Serum Levels of Caspase-Cleaved Cytokeratin-18 in Interstitial Lung Disease Associated with Rheumatoid Arthritis, Dermatomyositis, and Polymyositis. Journal of St. Marianna University 13:2, pages 113-125.
Crossref
Crossref
Qihua Yang, Tianfang Li, Xin Zhang, Kunlong Lyu, Shujun Wu, Yan Chen, Shengyun Liu & Zujiang Yu. (2021) Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Yasuhiro Kondoh, Shigeki Makino, Takashi Ogura, Takafumi Suda, Hiromi Tomioka, Hirofumi Amano, Masaki Anraku, Noriyuki Enomoto, Takao Fujii, Tomoyuki Fujisawa, Takahisa Gono, Masayoshi Harigai, Hidenori Ichiyasu, Yoshikazu Inoue, Takeshi Johkoh, Hideto Kameda, Kensuke Kataoka, Yasuhiro Katsumata, Yasushi Kawaguchi, Atsushi Kawakami, Hideya Kitamura, Noboru Kitamura, Tomohiro Koga, Kazuhiro Kurasawa, Yutaro Nakamura, Ran Nakashima, Yasuhiko Nishioka, Osamu Nishiyama, Masaki Okamoto, Fumikazu Sakai, Susumu Sakamoto, Shinji Sato, Toshimasa Shimizu, Noboru Takayanagi, Reoto Takei, Tamiko Takemura, Tohru Takeuchi, Yuko Toyoda, Hidehiro Yamada, Hideaki Yamakawa, Yasuhiko Yamano, Yoshioki Yamasaki & Masataka Kuwana. (2021) 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. Respiratory Investigation 59:6, pages 709-740.
Crossref
Crossref
Yuichiro Shirai, Ryosuke Fukue, Yuko Kaneko & Masataka Kuwana. (2021) Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease. Diagnostics 11:11, pages 2007.
Crossref
Crossref
Peiyan Zheng, Xiaomao Zheng, Hasegawa Takehiro, Zhangkai Jason Cheng, Jingxian Wang, Mingshan Xue, Quanming Lin, Zhifeng Huang, Huimin Huang, Chenxi Liao & Baoqing Sun. (2021) The prognostic value of Krebs von den Lungen-6 and surfactant protein-A levels in the patients with interstitial lung disease. Journal of Translational Internal Medicine 9:3, pages 212-222.
Crossref
Crossref
Shota Okamoto, Hiroto Tsuboi, Hisashi Noma, Daiki Tabuchi, Toshiki Sugita, Taihei Nishiyama, Toshihiko Terasaki, Masaru Shimizu, Fumika Honda, Mizuki Yagishita, Ayako Ohyama, Izumi Kurata, Saori Abe, Hiroyuki Takahashi, Atsumu Osada, Shinya Hagiwara, Yuya Kondo, Isao Matsumoto & Takayuki Sumida. (2021) Predictive Factors for Pneumomediastinum During Management of Connective Tissue Disease-related Interstitial Lung Disease: A Retrospective Study. Internal Medicine 60:18, pages 2887-2897.
Crossref
Crossref
Norio Hanata, Yasuo Nagafuchi, Yusuke Sugimori, Satomi Kobayashi, Yumi Tsuchida, Yukiko Iwasaki, Hirofumi Shoda & Keishi Fujio. (2021) Serum Amphiregulin and Heparin-Binding Epidermal Growth Factor as Biomarkers in Patients with Idiopathic Inflammatory Myopathy. Journal of Clinical Medicine 10:16, pages 3730.
Crossref
Crossref
Takahisa Gono, Kenichi Masui, Naoshi Nishina, Yasushi Kawaguchi, Atsushi Kawakami, Kei Ikeda, Yohei Kirino, Yumiko Sugiyama, Yoshinori Tanino, Takahiro Nunokawa, Yuko Kaneko, Shinji Sato, Katsuaki Asakawa, Taro Ukichi, Shinjiro Kaieda, Taio Naniwa, Yutaka Okano, Masataka Kuwana, Yukie Yamaguchi, Yoshinori Taniguchi, Jun Kikuchi, Makoto Kubo, Masaki Watanabe, Tatsuhiko Harada, Taisuke Kazuyori, Hideto Kameda, Makoto Kaburaki, Yasuo Matsuzawa, Shunji Yoshida, Yasuko Yoshioka, Takuya Hirai, Yoko Wada, Koji Ishii, Sakuhei Fujiwara, Takeshi Saraya, Kozo Morimoto, Tetsu Hara, Hiroki Suzuki, Hideki Shibuya, Yoshinao Muro, Ryoichi Aki, Takuo Shibayama, Shiro Ohshima, Yuko Yasuda, Masaki Terada & Yoshie Kawahara. (2021) Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis–Associated Interstitial Lung Disease. Arthritis & Rheumatology 73:4, pages 677-686.
Crossref
Crossref
Sara Tomassetti, Thomas V. Colby, Athol U. Wells, Venerino Poletti, Ulrich Costabel & Marco Matucci-Cerinic. (2021) Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110596.
Crossref
Crossref
Jingxian Wang, Peiyan Zheng, Zhifeng Huang, Huimin Huang, Mingshan Xue, Chenxi Liao, Baoqing Sun & Nanshan Zhong. (2020) Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Yukai Wang, Shaoqi Chen, Jianqun Lin, Xuezhen Xie, Shijian Hu, Qisheng Lin, Kedi Zheng, Guangzhou Du, Xiufeng Huang, Guohong Zhang, Luna Gargani, Marco Matucci-Cerinic & Daniel E Furst. (2020) Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease. Rheumatology 59:8, pages 2024-2029.
Crossref
Crossref
Shinjiro Kaieda, Takahisa Gono, Kenichi Masui, Naoshi Nishina, Shinji Sato & Masataka Kuwana. (2020) Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease. PLOS ONE 15:6, pages e0234523.
Crossref
Crossref
Hideaki Yamakawa, Eri Hagiwara, Satoshi Ikeda, Tae Iwasawa, Ryota Otoshi, Erina Tabata, Ryo Okuda, Akimasa Sekine, Tomohisa Baba, Shinichiro Iso, Koji Okudela, Tamiko Takemura & Takashi Ogura. (2019) Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia. Respiratory Investigation 57:5, pages 422-429.
Crossref
Crossref
Tomoyuki Fujisawa, Hironao Hozumi, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui & Takafumi Suda. (2019) Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody–positive Dermatomyositis-associated Interstitial Lung Disease. The Journal of Rheumatology 46:8, pages 935-942.
Crossref
Crossref
Charles Cassius, Hélène Le Buanec, Jean-David Bouaziz & Reyhan Amode. (2019) Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome. Journal of Immunology Research 2019, pages 1-15.
Crossref
Crossref
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2018) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Neurology and Clinical Neuroscience 7:1, pages 3-21.
Crossref
Crossref
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2019) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. The Journal of Dermatology 46:1, pages e1-e18.
Crossref
Crossref
Kazuhiro Kurasawa, Satoko Arai, Yumeko Namiki, Ayae Tanaka, Yuta Takamura, Takayoshi Owada, Masafumi Arima & Reika Maezawa. (2018) Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. Rheumatology 57:12, pages 2114-2119.
Crossref
Crossref
Jumpei Hisanaga, Takuya Kotani, Youhei Fujiki, Shuzo Yoshida, Tohru Takeuchi & Shigeki Makino. (2017) Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis. International Journal of Rheumatic Diseases 20:12, pages 2182-2185.
Crossref
Crossref
Katsuhiro Oda, Takuya Kotani, Tohru Takeuchi, Takaaki Ishida, Takeshi Shoda, Kentaro Isoda, Shuzo Yoshida, Yasuichiro Nishimura & Shigeki Makino. (2017) Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study. Scientific Reports 7:1.
Crossref
Crossref
Yasuhiro Shimojima, Wataru Ishii, Masayuki Matsuda, Dai Kishida & Shu-ichi Ikeda. (2017) Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis. JCR: Journal of Clinical Rheumatology 23:2, pages 87-93.
Crossref
Crossref
M. Kristen Demoruelle, Shikha Mittoo & Joshua J. Solomon. (2016) Connective tissue disease-related interstitial lung disease. Best Practice & Research Clinical Rheumatology 30:1, pages 39-52.
Crossref
Crossref
Norimoto Kobayashi, Ichiro Kobayashi, Masaaki Mori, Shinji Sato, Naomi Iwata, Tomonari Shigemura, Kazunaga Agematsu, Shumpei Yokota & Kenichi Koike. (2015) Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis. The Journal of Rheumatology 42:12, pages 2412-2418.
Crossref
Crossref
Takuya Kotani, Tohru Takeuchi, Takaaki Ishida, Ryota Masutani, Kentaro Isoda, Kenichiro Hata, Shuzo Yoshida, Shigeki Makino & Toshiaki Hanafusa. (2015) Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study. PLOS ONE 10:10, pages e0140117.
Crossref
Crossref
Deborah Assayag & Christopher J. Ryerson. (2015) Determining Respiratory Impairment in Connective Tissue Disease?Associated Interstitial Lung Disease. Rheumatic Disease Clinics of North America 41:2, pages 213-223.
Crossref
Crossref
Kentaro Isoda, Tohru Takeuchi, Takuya Kotani, Kenichiro Hata, Takeshi Shoda, Takaaki Ishida, Shuzo Yoshida, Yuko Kimura, Shigeki Makino & Toshiaki Hanafusa. (2014) Pre-Treatment Ferritin Level and Alveolar-Arterial Oxygen Gradient Can Predict Mortality Rate Due to Acute/Subacute Interstitial Pneumonia in Dermatomyositis Treated by Cyclosporine A/Glucocorticosteroid Combination Therapy: A Case Control Study. PLoS ONE 9:2, pages e89610.
Crossref
Crossref